Abstract
EVER VER since quinacrine hydrochloride was introduced into the therapyof malaria, it has been considered a most valuable addition to the series of antimalarial drugs, owing to its well established effectiveness, together with its relatively low toxicity. This evaluation of the drug has not changed, even though reports of toxic effects after therapeutic doses and, in particular, of mental disorders following treatment with the drug were described as early as 1933. In that year Conoley1gave an unpublished report on psychosis following treatment with quinacrine. In 1934 Kingsbury,2utilizing observations of his own, as well as of others (Cameron,3Green,4Hoops,5McSwan,6Quaife7), collected a series of 12 cases of psychoses associated with quinacrine therapy, with the records available, which had been observed in the Malay States. Six more cases were published by Banerjee8in 1936, from India. Decherd,9in 1937,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.